Loading...

India Globalization Capital, Inc.

IGC•AMEX
Industrials
Conglomerates
$0.41
$0.05(13.39%)

India Globalization Capital, Inc. (IGC) Stock Overview

Explore India Globalization Capital, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.8/100

Key Financials

Market Cap32.9M
P/E Ratio-4.87
EPS (TTM)$-0.12
ROE-1.02%
Fundamental Analysis

AI Price Forecasts

1 Week$0.30
1 Month$0.31
3 Months$0.46
1 Year Target$0.19

IGC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of India Globalization Capital, Inc. (IGC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 83.90, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.87 and a market capitalization of 32.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

83.90RSI (14)
0.01MACD
28.25ADX
Revenue Growth
47.64%
↑ 47.64%
Profit Growth
$-0.09
↓ 13.63%
EPS Growth
$-0.09
Operating Margin
-585.84%
↑ 15.32%
ROE
-102.29%
↓ 13.63%
Dividend Yield
0.00%
Analyst Recommendations data is not available for IGCAnalyst Recommendations details for IGC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. It operates through two segments, Infrastructure and Life Sciences. The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand. The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts. It operates in the United States, India, Colombia, and Hong Kong. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

CEO

Ram Mukunda

Employees

67

Headquarters

10224 Falls Road, Potomac, MD

Founded

2006

Frequently Asked Questions

;